Analysts recently trimmed their fair value estimate for PTC Therapeutics from US$87.93 to US$86.50, a modest 1.6% cut that captures a slightly more cautious stance. This shift sits alongside a wide ...
Pulmonx is back in focus after analysts trimmed the price target from US$6 to US$5, while keeping a model fair value estimate of US$5.17 per share unchanged. This shift reflects a mixed read on the ...
Like a Prayer saw Madonna ascend on both a thematic and musical level, but its provocative video pushed the buttons of the ...
COLUMBUS, Ohio -- Ohio State invited its student body to get a sneak preview of its 2024 football team for spring practice No ...
When looking forward to the draft it is hard to tell which direction (i.e., position the Vikings will take at 18). The ...
Riot Platforms’ model fair value per share has been adjusted slightly, moving from US$25.94 to US$25.84. This small change reflects a research backdrop where many firms are trimming price targets on ...
Bake an uncooked ham at an oven temperature of 325 degrees Fahrenheit, covered, until it reaches a safe internal temperature ...
A U.S.-Iran war 'tax' is beginning to hit consumers as diesel and jet fuel prices rise and stress business profitability, and ...
One name to keep an eye on is Boston College's Logan Taylor, who met with Patriots head coach Mike Vrabel at his pro day in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results